SCHEMBL3593360

SCHEMBL3593360

Cc1ccc(-c2ccc3ccn(CC(=O)NC(Cc4ccccc4)CN4CCCC4)c3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 6/20 0.45
▸ ALDH1A1 P00352 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ APOBEC3A P31941 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ RAD52 P43351 1/20 0.40
▸ AVPR1B P47901 1/20 0.40
▸ GLA P06280 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MME P08473 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MCHR1 Q99705 1/20 0.38
▸ MMEL1 Q495T6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605733 0.84 ALDH1A1 (0.48) NTSR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL3598861 0.83 ALDH1A1 (0.47) NTSR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL3605190 0.76 KMT2A (0.49) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL3602569 0.75 KMT2A (0.48) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL3597719 0.75 KMT2A (0.48) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL3593133 0.74 GRIN2B (0.43) NTSR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL3605111 0.72 KMT2A (0.44) NTSR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL3608528 0.72 MTNR1A (0.47) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL3595366 0.71 DRD3 (0.41) NTSR1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL7998427 0.71 MME (0.53) HPGDMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 — — US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 — — US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 NTSR1 1072/4885ALDH1A1 662/4885KDM4E 4801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback